Treatment strategies in cannabis consumers and patients with associated psychic disorders;Cannabiskonsum und assoziierte psychische störungen: Behandlungsstrategien

Nervenheilkunde

Volumn 26, Issue 6, 2007, Pages 481-486

  Taschner K L ^a  

^a KLINIKUM STUTTGART   (Germany)

Author keywords

Cannabis associated disorders; Cannabis induced psychosis; Treatment programs

Indexed keywords

CANNABIS;

ARTICLE; COGNITIVE DEFECT; DISEASE COURSE; DRUG USE; GERMANY; HEALTH PROGRAM; HUMAN; INTOXICATION; PSYCHOSIS; UNITED STATES; WITHDRAWAL SYNDROME;

EID: 34347347179     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1626889     Document Type: Article

References (40)

1. Arseneault L, Cannon R, Poulton R, Murray A, Caspi TE, Mofflitt. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Brit Med J 2002; 325: 1212-1213.
2. Ashton CH. Pharmacology and effect of cannabis: a brief review. Brit J Psych. 2001; 178: 101-106.
3. Axelrod J, Felder CC. Cannabinoid rezeptors and their endogenous agonist: Anandamide. Neurochem Res 1988; 23: 575-81.
4. Bonnet U, Harries-Hedder K, Leweke FM, Schneider U, Tossmann P. AWMF-Leitlinie: Cannabis-bezogene Storungen. Fortschr Neurol Psychiat 2004; 72: 318-329.
5. Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psych 2001; 158: 2033-2037.
6. Boydell J, van Os J, Lambri M, Castle D, Allardyce J, Mc Creadle RG, Murray RM. Incidence of schizophrenia in south-east London between 1965 and 1997. Brit J Psych 2003; 182: 45-49.
7. Brady KT. Relationship between substance abuse and bipolar disorder. J Clin Psych 1995, 56 (Suppl).
8. Budney AJ, Hughes JR, Moore BA, Novy PL. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psych 2001; 58: 917-924.
9. Budney AJ, Higgins ST, Radonovic KJ, Novy PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 2000; 68: 1051-1061.
10. Budney, AJ., Moore BA, Vandrey RG, Hughes. The time course and significance of cannabis withdrawal.J. Abnorm. Pychol 2003; 112: 393-402.
11. Bühringer G, Kraus L, Augustin R. Prävalenz des Konsum psychoaktiver Substanzen und Zahl der jährlichen Behandlungsfälle in Deutschland. IFT 2002.
12. Copeland J, Swift W, Roffman RA, Stephens RS. A randomised controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abuse Treatment 2001; 21: 55-64.
13. Degenhardt L, Hall W, Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alc Dep 2003; 71: 37-48.
14. Dennis M, Titus JC, Diamond G, Donaldson J, Godley SH, Tims FM, Webb C, Kaminer Y, Babor T, Roebuck MC, Godley MD, Hamilton N, Liddle H, Scott CK. The Cannabis Youth Treatment (CYT) experiment: rationale, study design and analysis plan. Addiction 2002; 97 (Suppl 1), 16-34.
15. Department of Environment, Transport and the Regions (DETR). Report on incidence of drugs in road accident victims. London 1998.
16. Fischer J, Täschner KL. Flashback nach Cannabiskonsum- eine Übersicht. Fortschr Neurol Psycbiat 1991; 59: 437-446.
17. Gouzoulis-Mayfrank E. Komorbidität Psychose und Sucht. Darmstadt: Steinkopff 2003.
18. Gouzoulis-Mayfrank E. Doppeldiagnosen Psychose und Sucht. Nervenarzt 2004; 75: 642-650.
19. Johns A. Psychiatric effects of cannabis. Brit J Psych 2001; 178: 116-122.
20. Kouri EM, Pope HGJr, Lukas SE. Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology 1999; 143: 302-308.
21. Kraus L, Augustin R. Repräsentativerhebung zum Gebrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland 2000. Sucht (Sonderheft) 2001; 47.
22. Kraus L, Augustin R, Orth B. Illegale Drogen, Einstiegsalter und Trends. Sucht 2005; 51: 19-28 Sonderheft 1.
23. Kraus L, Orth B, Kunz-Ebrecht SR. Alter des Erstkonsums bei Cannabis: Altersverschiebung oder mehr Einsteiger? In: Jahrbuch Sucht 2004 (Hrsg. Deutsche Hauptstelle für Suchtfragen). Geesthacht: Neuland Verlag 2003.
24. Moreau de Tours JJ. Du hachich et de alienation mentale. Libraire de Fortin, Masson, Paris 1845 engl.: Raven Press, New York City 1971.
25. Rommelspacher H. Pharmakologische Grundlagen der Verwendung von Cannabinoiden als Medikamente. In: Fischer J (Hrsg). Weggefahrten - Festschrift zum 60. Geburtstag von Prof. Dr. Karl-Ludwig Täschner. Lengerich, Berlin: Pabst Verlag 2003.
26. Seifert J, Schlimme J, Wedegärtner F, Emrich HM, Schneider Z. Cannabis und Schizophrenic. Sucht 2002; 48: 336-345.
27. Slikker W, Paule MG, Ali SF, Scarlett AC, Bailey JR. Behavioral neurochemical and neurohistological effects of chronic marjiuana smoke exposure in the nonhuman primate. In: Murphy L, Bartke A (eds). Marjuana, Cannabinoids: Neurobiology and Neurophysiology. Boca Raton: CRC Press 1992, 219-273.
28. Smith NT. A review of the published literature into cannabis withdrawal symptoms in human users. Addiction 2002; 97: 621-632.
29. Solowij N. Cannabis und Cognitive Functioning. Cambridge: University Press 1998.
30. Steinberg KL, Rebman RA, Carroll KM, Kabela E, Kadden R, Miller M, Duresky D. Tailoring cannabis dependence treatment for a diverse population. Suppl. 12002; 97: 135-142.
31. Stephens RS, Babor TF, Kadden R, Miller M. The Marijuana Treatment Project: rationale, design and participant characteristics Addiction 2002; 97: (Supp.1) 109-124.
32. Stephens RS, Roffman RA, Simpson EE. Treating adult marijuana dependence: a test of the relapse prevention model. J Consult Clin Psychology 1994; 62: 92-99.
33. Strike CJ, Urbanoski KA, Rush BR. Who seeks treatment for cannabis related problems? Canadian J Publ Health 2003; 94: 351-354.
34. Stringaris MG. Zur Klinik der Haschischpsychosen (Nach Studien in Griechenland). Arch Psychiat Nervenkr 1933; 100: 523-532.
35. Täschner KL. Rausch und Psychose. Stuttgart: Kohlhammer Verlag 1980.
36. Täschner KL. Zur Psychopathologie und Differentialdiagnose sogenannter Cannabispsychosen. Fortschr Neurol Psych 1983; 51: 235-248.
37. Van Os J, Bank M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a logitudin population - based study. Am J Epidemiol 2002; 156: 319-327.
38. Veen ND, Selten JP, van der Tweel I, Feller WG, Hoek HW, Kahn RS. Cannabis use and age at onset of schizophrenia. Am J Psych 2004; 161: 501-506.
39. Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, Barnes T, Bench C, Middleton H, Wright N, Paterson S, Shanahan W, Seivewright N, Ford C. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Brit J Psych 2003; 183: 304-313.
40. Wiesbeck GA, Schuckit MA, Kalmijn JE, Tripp E, Buchholz KK, Smith TL. An evaluation of the history of a marjuana withdrawal syndrome in a large population. Addiction 1996; 91: 1469-1478.